[Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Eydenzelt (CT-P42, Eylea Biosimilar) / 2025-02-14
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received final marketing authorization from the European Commission (EC) for Eydenzelt (CT-P42), a biosimilar to Eylea, covering major ophthalmic indications across 30 European countries. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of EC Marketing Authorization Listing in…